- Home
- LBRT vs PTGX Comparison
LBRT vs PTGX Comparison
Compare LBRT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LBRT | PTGX |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.2B |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | LBRT | PTGX |
|---|---|---|
| Price | $32.93 | $99.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | $24.42 | ★ $108.23 |
| AVG Volume (30 Days) | ★ 3.7M | 630.7K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $4,006,116,000.00 | N/A |
| Revenue This Year | $0.27 | $874.25 |
| Revenue Next Year | $7.44 | N/A |
| P/E Ratio | $36.17 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.90 | $41.29 |
| 52 Week High | $32.40 | $107.84 |
Technical Indicators
Market Signals| Indicator | LBRT | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 68.28 | 47.48 |
| Support Level | $26.72 | $95.40 |
| Resistance Level | N/A | $100.00 |
| Average True Range (ATR) | 1.51 | 4.19 |
| MACD | 0.48 | -0.63 |
| Stochastic Oscillator | 93.73 | 39.57 |
Price Performance
Historical ComparisonAbout LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.